{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62032-917",
      "generic_name": "HOMOSALATE, OCTISALATE, ZINC OXIDE",
      "labeler_name": "Obagi Cosmeceuticals LLC",
      "brand_name": "Obagi-C Fx System Normal-Oily Skin Brightening System with Arbutin",
      "finished": true,
      "packaging": [],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Obagi Cosmeceuticals LLC"
        ],
        "spl_set_id": [
          "321e58d0-9964-4da9-af6b-66ba81b60cf7"
        ],
        "is_original_packager": [
          true
        ]
      },
      "marketing_category": "UNAPPROVED DRUG OTHER",
      "dosage_form": "KIT",
      "spl_id": "a27a6106-f8cb-47e4-8e71-1f7dceb77d3d",
      "product_type": "HUMAN OTC DRUG",
      "marketing_start_date": "20191202",
      "product_id": "62032-917_a27a6106-f8cb-47e4-8e71-1f7dceb77d3d",
      "brand_name_base": "Obagi-C Fx System Normal-Oily Skin Brightening System with Arbutin"
    }
  ]
}